Every year, 900 preventable deaths from cardiovascular disease occur in Kentucky’s 5th congressional district alone, according to one health statistic cited recently by University of Kentucky president Eli Capilouto at the unveiling of UK HealthCare’s new Cardiovascular Inpatient Unit, a 64-bed hub on the eighth floor of Pavilion A at the Chandler Hospital. UK calls the unit one of the largest of its type in the country with 32 intensive care beds and 32 progressive care beds. “It’s a powerful day for the University of Kentucky, but more so for the commonwealth,” Capilouto told the crowd.
Read more »
At 81, Robert Kraus told his doctors he didn’t want a complicated, open-chest procedure to replace his aortic valve. That’s when he learned about a new, minimally invasive procedure now available at UK HealthCare known as TAVR, the latest advancement at the UK Gill Heart Institute.
Read more about Robert’s story and how TAVR helped him quickly return to his normal activities.
Hypertension is called "the silent killer" because there are not obvious symptoms. A UK cardiologist is leading a study to explore a new way to heal resistant hypertension.
A group of dedicated pharmacy students is proving that they can be the first line of defense against heart disease.
More than 100 patients, families and UK HealthCare staff celebrated an important milestone: the 25th anniversary of the first heart transplant at the University of Kentucky.
A new interactive technology currently being piloted in the UK Chandler Hospital's eighth floor cardiovascular unit aims to improve patient health literacy and make them partners in their care.
The Transplant Games of America's National Flag Tour will stop at UK HealthCare this Thursday, March 17, to celebrate organ donors and recipients on its way to the 2016 Games in Cleveland this June.
Tim is famous among his co-workers for hating meetings. Little did he know that a meeting called just before the tip-off of the UK/Florida SEC tournament game on March 13, 2015 would change his opinion forever.
The Gill Heart Institute has named two internationally-acclaimed scientists as recipients of the 2016 Gill Award in recognition of their lifelong achievements in the study of cardiovascular biology and disease.
The Gill Heart Institute has received a grant to explore effective ways of managing anticoagulation in patients who require procedures after their LVAD implant.
UK HealthCare has achieved Magnet Status – the highest institutional honor awarded for nursing excellence from the American Nurses Credentialing Center's (ANCC) Magnet Recognition Program.
Even people with the best of intentions to get heart-healthy in the new year become discouraged, and by now more than one in three of us have abandoned our New Year's resolutions. Dr. Gretchen Wells, director of women's heart health at the University of Kentucky's Gill Heart Institute, emphasizes that we don't have to exercise strenuously to achieve results.
The unspoken pact among Wildcat fans to always "Bleed Blue" was suspended last week in the Pavilion A atrium of Chandler Hospital long enough for supporters to "Go Red" for women's heart health.
Want a free chair massage? An aromatherapy hand massage? A chocolaty fruit treat? If you "Go Red" tomorrow, you can get all of this and more.
Many believe heart health involves strenuous tasks and countless hours at the gym. But just 30 minutes of exercise, five out of seven days a week can reduce heart attack risk by up to 50 percent.
While at UK we prefer to "See Blue," on Friday, Feb. 5, we will "Go Red" for a good cause.
Transplanted just five days apart, Stan Burch and Dennis Hamilton became fast friends at UK HealthCare as they underwent the recovery process together. The Louisville-area patients are two of the 43 patients who received a heart transplant at UK in 2015.
The University of Kentucky Transplant Center recently performed its 38th adult heart transplant for 2015, setting a record for the most heart transplants performed by a Kentucky medical center in a single year and easily eclipsing the previous state record of 27 heart transplants performed in a single year.
Analia Loria, assistant professor of pharmacology and nutritional sciences at the University of Kentucky, will be a featured presenter at the First Physiology and Gender Conference organized by the American Physiological Society this week.
The UK Gill Heart Institute and the UK Transplant Center are hosting the Advances in Heart Failure 2015 conference on Saturday, Oct. 24 in Pavilion A of the Albert B. Chandler Hospital.
Jon Wes and Gardner Adams share a lot. Both have a profound love for baseball. Both are in phenomenal physical condition. And as identical twins, they share the same genetic profile. It was that closeness — and the sharp minds of physicians at the Gill Heart Institute — that ultimately saved both their lives.
More than 130 UK HealthCare physicians practicing medicine with UK Albert B. Chandler Hospital, Kentucky Children's Hospital, UK Good Samaritan Hospital and Shriner's Hospitals for Children appear on the Best Doctors in America list for 2015-16 – more than any other hospital in Kentucky.
The National Cancer Institute (NCI) recently awarded a $750,000 grant to University of Kentucky researcher Fredrick Onono to study the potential link between obesity and breast cancer.
Without 116-pound Sarge the dog, Mryl Sizemore would have probably died of his heart attack. But Sarge needed the Gill Heart Institute's help as well in order to save Mryl's life.
Regenerative medicine offers great promise in the development of medical treatments for a wide range of conditions — including heart attacks. A former two-time state amateur golf champ and father of two daughters from Booneville is among those taking part in a clinical trial at Gill Heart Institute that is looking into the possibility that stem cell therapy can repair damaged heart tissue after a recent heart attack.
The University of Kentucky's Health Care Committee of the UK Board of Trustees were presented a strategic plan that will guide UK HealthCare through 2020. The committee met Thursday during their annual retreat.
Clinical trials of PCSK9 inhibitors appear to sharply reduce levels of bad (LDL) cholesterol. Gill Heart Institute's Dr. Thomas Whayne is optimistic that the drugs will be approved by the FDA, but sees some barriers to PCSK9 inhibitors' success.